Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial - Cohen, H; Hunt, B J; Efthymiou, M (Lancet Haematol, 2016)
, et al; RAPS trial investigators.